Acadia Pharmaceuticals stock price target lowered to $33 by H.C. Wainwright
Covered in this story
Tracked from this story
H.C. Wainwright’s $33 target on $ACAD is on the record and being tracked to Sep 2027 (12-month default), scored on the close that day.
H.C. Wainwright’s track record →Analyst targets on Acadia Pharmaceuticals Inc
- RBC Capital Markets: $20.1 → $37 by Oct 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ACAD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Acadia Pharmaceuticals Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.